Tenet Healthcare (NYSE:THC) Reaches New 12-Month High – Time to Buy?

Tenet Healthcare Corporation (NYSE:THC)’s stock price hit a new 52-week high during trading on Wednesday . The company traded as high as $265.83 and last traded at $265.58, with a volume of 169186 shares. The stock had previously closed at $259.45.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on THC shares. Robert W. Baird upped their target price on shares of Tenet Healthcare from $210.00 to $280.00 and gave the company a “neutral” rating in a research report on Tuesday, July 28th. UBS Group boosted their price objective on Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a research note on Monday, July 27th. Weiss Ratings downgraded Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 2nd. Morgan Stanley lifted their target price on Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a report on Monday, July 27th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a report on Monday, July 27th. Seventeen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $272.25.

Tenet Healthcare Price Performance

The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. The company has a market capitalization of $21.44 billion, a PE ratio of 10.27, a price-to-earnings-growth ratio of 0.99 and a beta of 1.23. The stock’s 50-day moving average is $203.92 and its two-hundred day moving average is $202.38.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm had revenue of $6.04 billion for the quarter, compared to analysts’ expectations of $5.43 billion. During the same quarter in the prior year, the firm posted $4.02 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, equities analysts predict that Tenet Healthcare Corporation will post 21.09 EPS for the current year.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Roy Blunt sold 600 shares of the business’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $262.68, for a total value of $157,608.00. Following the completion of the sale, the director directly owned 4,589 shares of the company’s stock, valued at $1,205,438.52. The trade was a 11.56% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Christopher S. Lynch sold 3,837 shares of the firm’s stock in a transaction that occurred on Monday, July 27th. The stock was sold at an average price of $243.44, for a total transaction of $934,079.28. Following the transaction, the director directly owned 9,568 shares in the company, valued at approximately $2,329,233.92. This trade represents a 28.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 41,375 shares of company stock valued at $9,793,347. Insiders own 0.97% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the company. Triumph Capital Management bought a new stake in shares of Tenet Healthcare in the third quarter valued at about $25,000. Activest Wealth Management purchased a new position in Tenet Healthcare during the 4th quarter valued at about $26,000. Elyxium Wealth LLC purchased a new stake in shares of Tenet Healthcare in the 4th quarter worth approximately $29,000. Canada Pension Plan Investment Board purchased a new position in Tenet Healthcare during the second quarter valued at approximately $35,000. Finally, Trust Co. of Vermont bought a new position in Tenet Healthcare in the second quarter worth approximately $37,000. 95.44% of the stock is owned by institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.